Ugur Sahin, co-founder and CEO of biotechnology company BioNTech Source: AAPDrug maker BioNTech is confident its vaccine, developed with Pfizer, is effective against two new COVID-19 variants.
Published
Presented by Jennifer Luu
Source: SBS
Skip to podcast episode content
Share this with family and friends
Drug maker BioNTech is confident its vaccine, developed with Pfizer, is effective against two new COVID-19 variants.
For health and support measures currently in place in response to the COVID-19 pandemic in your language, visit sbs.com.au/coronavirus
